BASIC RESEARCH
An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect
Rodrigo Araujo Fraga-SilvaI, Fabiana P Costa-FragaI, Frederico B De SousaII, Natalia AleninaIII, Michael BaderIII, Ruben D SinisterraII, Robson A S SantosI,
Corresponding author
I Instituto Nacional de Ciência e Tecnologia em Nanobiofarmacêutica INCT-Nanobiofar - Department of Physiology and Biophysics, Biological Science Institute.
II Instituto Nacional de Ciência e Tecnologia em Nanobiofarmacêutica INCT-Nanobiofar - Department of Chemistry, Exact Science Institute, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
III Max-Delbrück Center for Molecular Medicine, Berlin, Germany.
Read
1295
Timeswas read the article
367
Total PDF
928
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 27 | 3 | 30 |
| 2025 11 | 77 | 17 | 94 |
| 2025 10 | 43 | 6 | 49 |
| 2025 9 | 44 | 17 | 61 |
| 2025 8 | 32 | 4 | 36 |
| 2025 7 | 51 | 6 | 57 |
| 2025 6 | 31 | 2 | 33 |
| 2025 5 | 19 | 2 | 21 |
| 2025 4 | 43 | 1 | 44 |
| 2025 3 | 44 | 3 | 47 |
| 2025 2 | 61 | 3 | 64 |
| 2025 1 | 23 | 4 | 27 |
| 2024 12 | 18 | 3 | 21 |
| 2024 11 | 43 | 14 | 57 |
| 2024 10 | 20 | 16 | 36 |
| 2024 9 | 29 | 13 | 42 |
| 2024 8 | 39 | 16 | 55 |
| 2024 7 | 25 | 16 | 41 |
| 2024 6 | 21 | 16 | 37 |
| 2024 5 | 15 | 19 | 34 |
| 2024 4 | 16 | 26 | 42 |
| 2024 3 | 20 | 11 | 31 |
| 2024 2 | 17 | 15 | 32 |
| 2024 1 | 18 | 8 | 26 |
| 2023 12 | 11 | 14 | 25 |
| 2023 11 | 8 | 19 | 27 |
| 2023 10 | 12 | 22 | 34 |
| 2023 9 | 16 | 22 | 38 |
| 2023 8 | 16 | 13 | 29 |
| 2023 7 | 17 | 15 | 32 |
| 2023 6 | 17 | 3 | 20 |
| 2023 5 | 9 | 2 | 11 |
| 2023 4 | 5 | 3 | 8 |
| 2023 3 | 7 | 1 | 8 |
| 2023 2 | 3 | 9 | 12 |
| 2023 1 | 5 | 3 | 8 |
| 2022 12 | 26 | 0 | 26 |
Show all